In human medicine, diabetes mellitus (DM) is a well-documented cause of cardiac dysfunction, specifically diastolic dysfunction. Unlike patients with systolic dysfunction, patients with diastolic dysfunction have preserved pumping abilities.1 Although previous studies have identified high incidences of congestive heart failure in diabetic cats, this study was the first to prospectively evaluate the incidence of diastolic dysfunction in cats with DM.2 The purpose was to determine if cats with newly diagnosed DM acquired diastolic dysfunction similarly to humans and, secondarily, to determine if diastolic dysfunction progresses over time.
Thirty-two diabetic cats and 10 healthy age- and weight-matched controls were included in the study. All 32 cats with DM and 10 controls underwent baseline echocardiograms and Doppler blood pressure measurements. No evidence of systolic dysfunction was noted in any study cats. On initial evaluation, diastolic studies were completed in 21 of the 32 cats with DM and 5 of the 10 controls. Of the 21 cats with DM, 33% were normal and 67% had evidence of diastolic dysfunction. Of the 5 control cats, 80% were normal and 20% had evidence of diastolic dysfunction.
On 6-month follow-up examination, 17 of the 32 cats with DM had either died or were lost to follow-up or the owners declined follow-up. The remaining 15 cats with DM underwent recheck echocardiograms 6 months after initial assessment. Of these, 5 were in DM remission, whereas the remaining 10 required continued treatment with glargine +/- exenatide (a glucagon-like peptide-1-receptor agonist) therapy. Twelve of the cats with DM underwent diastolic studies at 6-month follow-up; 17% had normal diastolic studies, whereas 83% demonstrated diastolic dysfunction. Fewer cats in diabetic remission still had evidence of diastolic dysfunction (60%) as compared with cats not in remission (100%). None of the cats developed congestive heart failure secondary to diastolic dysfunction.
